|
Desvenlafaxine Succinate
|
D000069468 |
[A cyclohexanol and phenol derivative and metabolite of venlafaxine that functions as a SEROTONIN AND NORADRENALINE REUPTAKE INHIBITOR (SNRI) and is used as an ANTIDEPRESSIVE AGENT.
] |
|
Detergents
|
D003902 |
[Single-use containers of detergent used for laundry and dish washing.
, Purifying or cleansing agents, usually salts of long-chain aliphatic bases or acids, that exert cleansing (oil-dissolving) and antimicrobial effects through a surface action that depends on possessing both hydrophilic and hydrophobic properties.
] |
|
Deubiquitinating Enzyme CYLD
|
D000074749 |
[A deubiquitinase and tumor-suppressor protein that specifically cleaves LYSINE-63-linked polyubiquitin chains and also has endodeubiquitinase activity. It functions to regulate NF-KAPPA B and WNT SIGNALING PATHWAY activity, contributing to cell survival, proliferation, and differentiation. Mutations in the CYLD gene are associated with cases of FAMILIAL CYLINDROMATOSIS.
] |
|
Deubiquitinating Enzymes
|
D000072017 |
[Enzymes that remove UBIQUITIN from a protein substrate, including POLYUBIQUITIN, or from other molecules.
] |
|
Deuterium
|
D003903 |
[The stable isotope of hydrogen. It has one neutron and one proton in the nucleus.
] |
|
Deuterium Exchange Measurement
|
D041961 |
[A research technique to measure solvent exposed regions of molecules that is used to provide insight about PROTEIN CONFORMATION.
] |
|
Deuterium Oxide
|
D017666 |
[The isotopic compound of hydrogen of mass 2 (deuterium) with oxygen. (From Grant & Hackh's Chemical Dictionary, 5th ed) It is used to study mechanisms and rates of chemical or nuclear reactions, as well as biological processes.
] |
|
Deuteroporphyrins
|
D003905 |
[Porphyrins with four methyl and two propionic acid side chains attached to the pyrrole rings.
] |
|
Devazepide
|
D020109 |
[A derivative of benzodiazepine that acts on the cholecystokinin A (CCKA) receptor to antagonize CCK-8's (SINCALIDE) physiological and behavioral effects, such as pancreatic stimulation and inhibition of feeding.
] |
|
Developed Countries
|
D019049 |
[Countries that have reached a level of economic achievement through an increase of production, per capita income and consumption, and utilization of natural and human resources.
] |
|
Developing Countries
|
D003906 |
[Countries in the process of change with economic growth, that is, an increase in production, per capita consumption, and income. The process of economic growth involves better utilization of natural and human resources, which results in a change in the social, political, and economic structures.
] |
|
Developmental Biology
|
D015509 |
[The field of biology which deals with the process of the growth and differentiation of an organism.
, Study of human growth and development.
] |
|
Developmental Disabilities
|
D002658 |
[Disorders in which there is a delay in development based on that expected for a given age level or stage of development. These impairments or disabilities originate before age 18, may be expected to continue indefinitely, and constitute a substantial impairment. Biological and nonbiological factors are involved in these disorders. (From American Psychiatric Glossary, 6th ed)
] |
|
Developmental Disability Nursing
|
D000084882 |
[Providing care for special needs patients with intellectual or other developmental needs.
] |
|
Developmental Dysplasia of the Hip
|
D000082602 |
[Dislocation of the HIP JOINT from an abnormal FEMORAL HEAD to the ACETABULUM relationship. It is most often due to ligamentous laxity, abnormal positioning of the joint and various other developmental, congenital factors, and method of delivery (e.g., OLIGOHYDRAMNIOS). When dislocation is diagnosed in neonates it is referred to as CONGENITAL HIP DYSPLASIA.
] |
|
Device Approval
|
D018795 |
[Process that is gone through in order for a device to receive approval by a government regulatory agency. This includes any required preclinical or clinical testing, review, submission, and evaluation of the applications and test results, and post-marketing surveillance. It is not restricted to FDA.
] |
|
Device Removal
|
D020878 |
[Removal of an implanted therapeutic or prosthetic device.
] |
|
Dexamethasone
|
D003907 |
[An anti-inflammatory 9-fluoro-glucocorticoid.
] |
|
Dexamethasone Isonicotinate
|
D003908 |
[An anti-inflammatory, anti-allergic glucocorticoid that can be administered orally, by inhalation, locally, and parenterally. It may cause water and salt retention.
] |
|
Dexetimide
|
D003909 |
[A muscarinic antagonist that has been used to treat neuroleptic-induced parkinsonism. Benzetimide is the (-)-enantimorph of dexetimide.
] |